Eli Lilly Reports Quarterly Results Above Wall Street Estimates
Eli Lilly reported EPS of $7.48, above the $6.26 estimate cited in the report. Sales of its weight-loss drugs continue to accelerate, the report says.
Pharmaceutical company Eli Lilly (LLY) has reported quarterly financial results that soared past Wall Street estimates as sales of its weight-loss drugs continue to accelerate.The Indianapolis, Indiana-based company announced earnings per share (EPS) of $7.48 U.S., which topped the $6.26 U.S. that…